A detailed history of Rothschild Investment LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Rothschild Investment LLC holds 90 shares of CPRX stock, worth $2,153. This represents 0.0% of its overall portfolio holdings.

Number of Shares
90
Previous 40 125.0%
Holding current value
$2,153
Previous $620,000 188.55%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$15.19 - $21.35 $759 - $1,067
50 Added 125.0%
90 $1.79 Million
Q2 2024

Jul 30, 2024

BUY
$14.68 - $16.92 $587 - $676
40 New
40 $620,000
Q1 2024

Jul 31, 2024

SELL
$13.18 - $17.11 $395 - $513
-30 Reduced 75.0%
10 $159,000

Others Institutions Holding CPRX

About CATALYST PHARMACEUTICALS, INC.


  • Ticker CPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,820,000
  • Market Cap $2.46B
  • Description
  • Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...
More about CPRX
Track This Portfolio

Track Rothschild Investment LLC Portfolio

Follow Rothschild Investment LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment LLC with notifications on news.